Bausch & Lomb Corp Capital Expenditures Incurred but Not yet Paid
Bausch & Lomb Corp (BLCO) reported Capital Expenditures Incurred but Not yet Paid of $29.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-07-29
- Bausch & Lomb Corp capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was -$13.00M.
- Bausch & Lomb Corp capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $42.00M, a 19.23% decline year-over-year.
- Bausch & Lomb Corp capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $5.00M, a 44.44% decline year-over-year.
- Bausch & Lomb Corp capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $3.00M.
- Bausch & Lomb Corp capital expenditures incurred but not yet paid for fiscal 2025 was $51.00M, a 8.93% decline from fiscal 2024.
- Bausch & Lomb Corp capital expenditures incurred but not yet paid for fiscal 2024 was $56.00M, a 13.85% decline from fiscal 2023.
- Bausch & Lomb Corp capital expenditures incurred but not yet paid for fiscal 2023 was $65.00M, a 71.05% increase from fiscal 2022.
- Bausch & Lomb Corp capital expenditures incurred but not yet paid for fiscal 2022 was $38.00M, a 22.58% increase from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$13.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $29.00M 10-Q · filed 2026-07-29 | $34.00M derived: sum of 3 quarters · filed 2026-07-29 | $37.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $42.00M 10-Q · filed 2026-04-29 | $47.00M derived: sum of 2 quarters · filed 2026-04-29 | $50.00M derived: sum of 3 quarters · filed 2026-04-29 | $41.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $8.00M derived: sum of 2 quarters · filed 2026-02-18 | -$1.00M derived: sum of 3 quarters · filed 2026-07-29 | $51.00M 10-K · filed 2026-02-18 |
| 2025-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$6.00M derived: sum of 2 quarters · filed 2026-07-29 | $46.00M 10-Q · filed 2025-10-29 | $55.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | -$9.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $43.00M 10-Q · filed 2026-07-29 | $52.00M derived: sum of 3 quarters · filed 2026-07-29 | $50.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $52.00M 10-Q · filed 2026-04-29 | $61.00M derived: sum of 2 quarters · filed 2026-04-29 | $59.00M derived: sum of 3 quarters · filed 2026-04-29 | $56.00M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $7.00M derived: sum of 2 quarters · filed 2026-02-18 | $4.00M derived: sum of 3 quarters · filed 2026-02-18 | $56.00M 10-K · filed 2026-02-18 |
| 2024-09-30 | -$2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$5.00M derived: sum of 2 quarters · filed 2025-10-29 | $47.00M 10-Q · filed 2025-10-29 | $78.00M derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-06-30 | -$3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $49.00M 10-Q · filed 2025-07-30 | $80.00M derived: sum of 3 quarters · filed 2026-02-18 | $88.00M derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-03-31 | $52.00M 10-Q · filed 2025-04-30 | $83.00M derived: sum of 2 quarters · filed 2026-02-18 | $91.00M derived: sum of 3 quarters · filed 2026-02-18 | $95.00M derived: sum of 4 quarters · filed 2026-02-18 |
| 2023-12-31 | $31.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $39.00M derived: sum of 2 quarters · filed 2026-02-18 | $43.00M derived: sum of 3 quarters · filed 2026-02-18 | $65.00M 10-K · filed 2026-02-18 |
| 2023-09-30 | $8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $12.00M derived: sum of 2 quarters · filed 2024-10-30 | $34.00M 10-Q · filed 2024-10-30 | $54.00M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $26.00M 10-Q · filed 2024-08-01 | $46.00M derived: sum of 3 quarters · filed 2025-02-19 | $43.00M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-03-31 | $22.00M 10-Q · filed 2024-05-01 | $42.00M derived: sum of 2 quarters · filed 2025-02-19 | $39.00M derived: sum of 3 quarters · filed 2025-02-19 | |
| 2022-12-31 | $20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $17.00M derived: sum of 2 quarters · filed 2025-02-19 | $38.00M 10-K · filed 2025-02-19 | |
| 2022-09-30 | -$3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $18.00M 10-Q · filed 2023-11-01 | ||
| 2022-06-30 | $21.00M 10-Q · filed 2023-08-02 | |||
| 2021-12-31 | $31.00M 10-K · filed 2024-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B |